BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35879546)

  • 1. O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1.
    Zhu Q; Zhou H; Wu L; Lai Z; Geng D; Yang W; Zhang J; Fan Z; Qin W; Wang Y; Zhou R; Yi W
    Nat Chem Biol; 2022 Oct; 18(10):1087-1095. PubMed ID: 35879546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer.
    Wang YP; Zhou W; Wang J; Huang X; Zuo Y; Wang TS; Gao X; Xu YY; Zou SW; Liu YB; Cheng JK; Lei QY
    Mol Cell; 2016 Nov; 64(4):673-687. PubMed ID: 27840030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.
    Yang C; Hu JF; Zhan Q; Wang ZW; Li G; Pan JJ; Huang L; Liao CY; Huang Y; Tian YF; Shen BY; Chen JZ; Wang YD; Chen S
    Genomics; 2021 Mar; 113(2):827-842. PubMed ID: 33515675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity for Kras
    Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P
    Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells.
    Hu CM; Tien SC; Hsieh PK; Jeng YM; Chang MC; Chang YT; Chen YJ; Chen YJ; Lee EYP; Lee WH
    Cell Metab; 2019 Jun; 29(6):1334-1349.e10. PubMed ID: 30853214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma.
    New M; Van Acker T; Sakamaki JI; Jiang M; Saunders RE; Long J; Wang VM; Behrens A; Cerveira J; Sudhakar P; Korcsmaros T; Jefferies HBJ; Ryan KM; Howell M; Tooze SA
    Cancer Res; 2019 Apr; 79(8):1884-1898. PubMed ID: 30765601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation.
    Yang SZ; Xu F; Yuan K; Sun Y; Zhou T; Zhao X; McDonald JM; Chen Y
    Lab Invest; 2020 May; 100(5):777-785. PubMed ID: 31896813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of
    Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
    J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Heterozygosity for
    Ma Y; Ling S; Li Y; Hu M; Kong B; Huang P; Liu H
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
    Son J; Lyssiotis CA; Ying H; Wang X; Hua S; Ligorio M; Perera RM; Ferrone CR; Mullarky E; Shyh-Chang N; Kang Y; Fleming JB; Bardeesy N; Asara JM; Haigis MC; DePinho RA; Cantley LC; Kimmelman AC
    Nature; 2013 Apr; 496(7443):101-5. PubMed ID: 23535601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop.
    Fujimura K; Wang H; Watson F; Klemke RL
    Cancer Res; 2018 Mar; 78(6):1444-1456. PubMed ID: 29321164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction.
    He X; Li Y; Chen Q; Zheng L; Lou J; Lin C; Gong J; Zhu Y; Wu Y
    Cell Death Differ; 2022 Oct; 29(10):1970-1981. PubMed ID: 35422493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer.
    Humpton TJ; Alagesan B; DeNicola GM; Lu D; Yordanov GN; Leonhardt CS; Yao MA; Alagesan P; Zaatari MN; Park Y; Skepper JN; Macleod KF; Perez-Mancera PA; Murphy MP; Evan GI; Vousden KH; Tuveson DA
    Cancer Discov; 2019 Sep; 9(9):1268-1287. PubMed ID: 31263025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
    Raho S; Capobianco L; Malivindi R; Vozza A; Piazzolla C; De Leonardis F; Gorgoglione R; Scarcia P; Pezzuto F; Agrimi G; Barile SN; Pisano I; Reshkin SJ; Greco MR; Cardone RA; Rago V; Li Y; Marobbio CMT; Sommergruber W; Riley CL; Lasorsa FM; Mills E; Vegliante MC; De Benedetto GE; Fratantonio D; Palmieri L; Dolce V; Fiermonte G
    Nat Metab; 2020 Dec; 2(12):1373-1381. PubMed ID: 33230296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.